Devanand Sarkar

22.0k total citations · 3 hit papers
295 papers, 17.4k citations indexed

About

Devanand Sarkar is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Devanand Sarkar has authored 295 papers receiving a total of 17.4k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Molecular Biology, 125 papers in Oncology and 77 papers in Genetics. Recurrent topics in Devanand Sarkar's work include Cancer Mechanisms and Therapy (75 papers), Virus-based gene therapy research (73 papers) and CAR-T cell therapy research (40 papers). Devanand Sarkar is often cited by papers focused on Cancer Mechanisms and Therapy (75 papers), Virus-based gene therapy research (73 papers) and CAR-T cell therapy research (40 papers). Devanand Sarkar collaborates with scholars based in United States, India and South Korea. Devanand Sarkar's co-authors include Paul B. Fisher, Luni Emdad, Swadesh K. Das, Zao-zhong Su, Luni Emdad, Seok‐Geun Lee, Irina V. Lebedeva, Saranya Chidambaranathan Reghupaty, Xiang‐Yang Wang and Paul Dent and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Devanand Sarkar

292 papers receiving 17.2k citations

Hit Papers

I nterleukin -10 and R elated C ytokines and R eceptors 2004 2026 2011 2018 2004 2020 2022 250 500 750

Peers

Devanand Sarkar
Jian Yu United States
Stanisław Krajewski United States
Paul B. Fisher United States
Eric W.‐F. Lam United Kingdom
David M. Hockenbery United States
John M. Sedivy United States
Paul Dent United States
Suzanne Cory Australia
Jian Yu United States
Devanand Sarkar
Citations per year, relative to Devanand Sarkar Devanand Sarkar (= 1×) peers Jian Yu

Countries citing papers authored by Devanand Sarkar

Since Specialization
Citations

This map shows the geographic impact of Devanand Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devanand Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devanand Sarkar more than expected).

Fields of papers citing papers by Devanand Sarkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devanand Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devanand Sarkar. The network helps show where Devanand Sarkar may publish in the future.

Co-authorship network of co-authors of Devanand Sarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Devanand Sarkar. A scholar is included among the top collaborators of Devanand Sarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devanand Sarkar. Devanand Sarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maji, Santanu, Amit Kumar, Praveen Bhoopathi, et al.. (2023). Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis. Molecular Cancer Therapeutics. 22(10). 1115–1127. 4 indexed citations
2.
Das, Swadesh K., Timothy P. Kegelman, Anjan K. Pradhan, et al.. (2019). Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor. Molecular Cancer Therapeutics. 18(11). 1997–2007. 22 indexed citations
3.
Pradhan, Anjan K., Praveen Bhoopathi, Sarmistha Talukdar, et al.. (2018). Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway. Molecular Cancer Therapeutics. 17(9). 1951–1960. 21 indexed citations
4.
Das, Swadesh K., Anjan K. Pradhan, Praveen Bhoopathi, et al.. (2018). The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion. Cancer Research. 78(11). 2852–2863. 42 indexed citations
5.
Jariwala, Nidhi, Devaraja Rajasekaran, Rachel G. Mendoza, et al.. (2017). Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma. Cancer Research. 77(12). 3306–3316. 50 indexed citations
6.
Pradhan, Anjan K., Sarmistha Talukdar, Praveen Bhoopathi, et al.. (2016). mda-7/IL-24 Mediates Cancer Cell–Specific Death via Regulation of miR-221 and the Beclin-1 Axis. Cancer Research. 77(4). 949–959. 49 indexed citations
7.
Bhoopathi, Praveen, Nathaniel Lee, Anjan K. Pradhan, et al.. (2016). mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM. Cancer Research. 76(12). 3572–3582. 31 indexed citations
8.
Robertson, Chadia L., Jyoti Srivastava, Ayesha Siddiq, et al.. (2014). Genetic Deletion of AEG-1 Prevents Hepatocarcinogenesis. Cancer Research. 74(21). 6184–6193. 44 indexed citations
9.
Hu, Bin, Luni Emdad, Manny D. Bacolod, et al.. (2014). Astrocyte Elevated Gene-1 Interacts with Akt Isoform 2 to Control Glioma Growth, Survival, and Pathogenesis. Cancer Research. 74(24). 7321–7332. 55 indexed citations
10.
Dash, Rupesh, Praveen Bhoopathi, Swadesh K. Das, et al.. (2013). Novel Mechanism of MDA-7/IL-24 Cancer-Specific Apoptosis through SARI Induction. Cancer Research. 74(2). 563–574. 42 indexed citations
11.
Dasgupta, Santanu, Mitchell E. Menezes, Swadesh K. Das, et al.. (2013). Novel Role of MDA-9/Syntenin in Regulating Urothelial Cell Proliferation by Modulating EGFR Signaling. Clinical Cancer Research. 19(17). 4621–4633. 53 indexed citations
12.
Das, Swadesh K., Sujit K. Bhutia, Upneet K. Sokhi, et al.. (2012). Raf Kinase Inhibitor RKIP Inhibits MDA-9/Syntenin-Mediated Metastasis in Melanoma. Cancer Research. 72(23). 6217–6226. 49 indexed citations
13.
Chen, Dong, Byoung Kwon Yoo, Prasanna K. Santhekadur, et al.. (2011). Insulin-like Growth Factor–Binding Protein-7 Functions as a Potential Tumor Suppressor in Hepatocellular Carcinoma. Clinical Cancer Research. 17(21). 6693–6701. 68 indexed citations
14.
Yoo, Byoung Kwon, Dong Chen, Zhao-zhong Su, et al.. (2010). Molecular Mechanism of Chemoresistance by Astrocyte Elevated Gene-1. Cancer Research. 70(8). 3249–3258. 105 indexed citations
15.
Emdad, Luni, Devanand Sarkar, Seok‐Geun Lee, et al.. (2010). Astrocyte Elevated Gene-1: A Novel Target for Human Glioma Therapy. Molecular Cancer Therapeutics. 9(1). 79–88. 87 indexed citations
16.
Bhutia, Sujit K., Rupesh Dash, Swadesh K. Das, et al.. (2010). Mechanism of Autophagy to Apoptosis Switch Triggered in Prostate Cancer Cells by Antitumor Cytokine Melanoma Differentiation-Associated Gene 7/Interleukin-24. Cancer Research. 70(9). 3667–3676. 102 indexed citations
17.
Yacoub, Adly, Hossein A. Hamed, Jeremy C. Allegood, et al.. (2010). PERK–Dependent Regulation of Ceramide Synthase 6 and Thioredoxin Play a Key Role in mda -7/IL-24–Induced Killing of Primary Human Glioblastoma Multiforme Cells. Cancer Research. 70(3). 1120–1129. 89 indexed citations
18.
Dash, Rupesh, Joanna E. Richards, Zhao-zhong Su, et al.. (2010). Mechanism by Which Mcl-1 Regulates Cancer-Specific Apoptosis Triggered by mda-7/IL-24, an IL-10–Related Cytokine. Cancer Research. 70(12). 5034–5045. 65 indexed citations
19.
20.
Gupta, Pankaj, Mark R. Walter, Zao-zhong Su, et al.. (2006). BiP/GRP78 Is an Intracellular Target for MDA-7/IL-24 Induction of Cancer-Specific Apoptosis. Cancer Research. 66(16). 8182–8191. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026